Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Investments:
Fixed maturities available-for-sale, at fair value (amortized cost of $68,087 and $68,636) (allowance for credit losses of $24 and $22)		$ 58,947	$ 73,076
Mortgage loans on real estate (net of allowance for credit losses of $129 and $62)		16,464	14,016
Policy loans		3,563	3,540
Other equity investments	[1]	2,942	2,759
Trading securities, at fair value		283	379
Other invested assets		2,835	2,910
Total investments		85,034	96,680
Cash and cash equivalents		797	1,815
Deferred policy acquisition costs		5,857	4,267
Amounts due from reinsurers (allowance for credit losses of [$—] and $5) (includes amounts accounted for at fair value of [$—] and $5,813)	[2]	15,885	13,300
Loans to affiliates		1,900	1,900
GMIB reinsurance contract asset, at fair value		1,306	2,068
Current and deferred income taxes		1,479	842
Other assets		3,898	3,023
Separate Accounts assets		111,479	143,912
Total Assets		227,635	267,807
LIABILITIES
Policyholders’ account balances		79,731	75,467
Future policy benefits and other policyholders' liabilities		33,536	36,851
Broker-dealer related payables		95	630
Amounts due to reinsurers		282	135
Other liabilities		3,951	2,078
Separate Accounts liabilities		111,479	143,912
Total Liabilities		229,074	259,073
Redeemable noncontrolling interest	[3]	21	28
Commitments and contingent liabilities	[4]
Equity attributable to Equitable Financial:
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding		2	2
Additional paid-in capital		8,536	8,546
Accumulated deficit		(1,986)	(2,199)
Accumulated other comprehensive income (loss)		(8,012)	2,357
Total Equity		(1,460)	8,706
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ 227,635	$ 267,807

[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.

[2] Represents the fair value of the ceded reserves to Venerable. See Note 1 of the Notes to these Consolidated Financial Statements for details of the Venerable Transaction and Note 7 of the Notes to these Consolidated Financial Statements.(4)See Note 16 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.

[3] See Note 18 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

[4] See Note 16 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.